Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Clinical Investigation · 2011-09 · 1 (9) · 1217-1235
DOI: 10.4155/cli.11.113 ↗At a glance
Journal article in Clinical Investigation, 2011-09. Written by Kate Bushby and 1 co-authors. Institution: Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK. Cited 134 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, NCRR NIH HHS.
Abstract (original language)
Niciun rezumat disponibil.
Authors and institutions
- Institute of Genetic Medicine, International Centre for Life, Newcastle University, Newcastle upon Tyne, UK.
Funding
- NICHD NIH HHS
- NCRR NIH HHS
Cite
APA
Bushby, K., & Connor, E. (2011). Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clinical Investigation, 1(9), 1217-1235. https://doi.org/10.4155/cli.11.113
Vancouver
Bushby K, Connor E. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clinical Investigation. 2011;1(9):1217-1235. doi:10.4155/cli.11.113
BibTeX
@article{Bushby2011,
author = {Bushby, Kate and Connor, Edward},
title = {Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings},
journal = {Clinical Investigation},
year = {2011},
volume = {1},
number = {9},
pages = {1217--1235},
doi = {10.4155/cli.11.113}
}
EUVIMED